What Is the Difference Between Vitrifying a Blastocyst and a Cleavage Stage Embryo?

The stage at which an embryo is vitrified affects the technical demands of the process, the survival rates achieved, and increasingly the clinical strategy UK IVF laboratories use when planning freeze-all cycles. The difference between vitrifying at cleavage stage (day 2 to 3) and blastocyst stage (day 5 to 6) is not simply a matter of timing – it involves meaningfully different biological and technical considerations.

Cleavage stage vitrification

At cleavage stage, the embryo consists of between 2 and 8 cells and has a relatively simple structure. The technical demands of vitrification at this stage are lower – the embryo is easier to load onto a carrier device, and the cryoprotectant equilibration steps are less time-sensitive than at blastocyst stage. Cleavage stage vitrification was more common in earlier years of IVF when extended culture to blastocyst was less reliable and culture media less advanced.

Blastocyst stage vitrification

By day 5 or 6, the embryo has developed into a blastocyst – a more complex structure with a fluid-filled cavity called the blastocoel. This cavity must be collapsed or artificially shrunk before vitrification to prevent the fluid from forming ice crystals during cooling. The process – called artificial shrinkage or blastocyst collapse – is performed by the embryologist immediately before loading. Blastocyst vitrification requires more precise timing and technique than cleavage stage, but the survival rates achieved in experienced UK laboratories are consistently higher.

Most UK IVF laboratories now culture to blastocyst and vitrify at day 5 or 6 as the default strategy for freeze-all cycles. The higher survival rates and better implantation potential of selected blastocysts make this the clinically preferred approach in most patient groups.

Consumable implications

The CBS High Security Vitrification Kits available through Cryolab are suitable for both cleavage stage and blastocyst vitrification. The equilibration and vitrification solution timings differ between stages – confirm the specific timings in your validated protocol before switching between stages. For protocol compatibility questions, contact Cryolab or use CryoGPT.